Severe Asthma ToolkitSevere Asthma Toolkit
HomeAboutSpecific PopulationsRegistriesContributorsContact
Twitter
  • What is Severe Asthma?
    • Overview
    • Definition
    • Prevalence & Burden
    • Pathophysiology
    • Symptoms
    • Severe Asthma Attacks / Exacerbations / Flare-ups
    • Asthma Phenotypes
  • Diagnosis & Assessment
    • Overview
    • Diagnosis Overview
    • Assessment Overview
    • Lung Function Assessments
    • Questionnaires
    • Allergy Assessments
    • Phenotyping
    • Bronchoscopy
    • Imaging
    • Occupational Asthma
  • Management
    • Overview
    • Asthma Education
      • About Severe Asthma
      • Asthma Pathophysiology
      • Medications Education
      • Self-Monitoring
      • Triggers
      • Review
    • Written Action Plans
    • Adherence
    • Inhaler Technique
    • Physical Activity & Exercise
    • Interdisciplinary Approach & Multidimensional Assessment
    • Referral
  • Medications
    • Overview
    • Relievers
    • Preventers / Controllers
    • Add-on Therapies
    • Monoclonal Antibodies
    • Bronchial Thermoplasty
  • Co-Morbidities
    • Overview
    • Pulmonary & Upper Airways
      • Allergic & Non-Allergic Rhinitis
      • Chronic Rhinosinusitis
      • Dysfunctional Breathing
      • Vocal Cord Dysfunction
      • Chronic Obstructive Pulmonary Disease
      • Bronchiectasis
      • Obstructive Sleep Apnoea
    • Extra-Pulmonary
      • Obesity
      • Anxiety & Depression
      • Gastro-oesophageal Reflux Disease (GORD)
      • Osteoporosis
      • Cardiovascular Disease & Metabolic Disease
  • Living with Severe Asthma
    • Overview
    • Daily Symptom Burden
    • Mental & Emotional Health
    • Intimacy & Relationships
    • Self-Management Support
    • Medication Use & Costs
    • Experience of Care
    • Experience of Asthma Attacks
    • Prognosis
  • Establishing a Clinic
    • Overview
    • Set-up
    • Staffing & Multidisciplinary Team Approach
    • Facilities
    • Delivery Approach
    • Tailored Referrals
    • Evaluation
    • Opportunities for Training & Research
    • Barriers & Hurdles
  • Paediatrics
    • Overview
    • Management in Paediatrics
    • Assessment in Paediatrics
    • Alternative Diagnosis & Co-Morbidities in Paediatrics
    • Psychosocial Issues in Paediatrics
    • Medications in Paediatrics
    • Asthma in the Adolescent Population
  • Resources
    • Overview
    • Clinic Recommendations
    • Infographics
    • Asthma Assessment Resources
    • Systematic & Multidimensional Assessment Resources
      • Airway Components
      • Comorbidity Components
      • Risk Factor Components
    • Translation & Implementation
    • Case Studies
    • Presentations
    • Videos
    • Relevant Links
    • Key References

Assessment in Paediatrics

Home Paediatrics & Adolescents Assessment in Paediatrics

Assessing Asthma in Paediatrics

a young boy during an asthma assessment, Assessing Asthma in Paediatrics

There are very few studies assessing the best approach to investigate severe asthma in the paediatric population. Clinical consensus suggests the following tests may be useful for confirming a diagnosis, ruling out differential diagnoses, monitoring disease severity or identifying contributing co-morbidities.

Respiratory Function Tests

Spirometry and Bronchodilator Response
Peak Expiratory Flow (PEF)
Forced Oscillation Technique (FOT) or Impulse Oscillation Technique (IOT)
Fraction Exhaled Oxide (FeNO)
Spirometry and Bronchodilator Response
  • Spirometry is recommended to help confirm diagnosis and for monitoring at each clinic visit, including FEV1, FEV1/FVC, FEF25-75% and bronchodilator response. For more information see Diagnosis – Lung Function Assessments
  • Standard spirometry is limited by the child’s ability to perform a dynamic airway manoeuvre. Generally, children aged over 5 years can perform spirometry.
  • The shape of the flow volume loop including inspiratory loops can help discriminate asthma from non-asthmatic upper airway obstruction
  • Children with severe asthma may have a normal FEV1 between exacerbations (van den Wijngaart et al. 2015).
  • Children with poorly controlled asthma may adapt to prolonged impaired lung function and report feeling ‘fine’ despite poor lung function, hence spirometry is essential in children from 5 years of age.
  • NOTE: In children with poorly controlled asthma, lung function may be poor with little or no bronchodilator responsiveness. Poor bronchodilator responsiveness is also typical during a viral exacerbation.
Peak Expiratory Flow (PEF)
  • Generally, not recommended in children for a number of reasons:
    • Primarily a measure of large airway patency, while peripheral airway disease is more important in severe asthma.
    • There is high inter-subject variation and results are effort-dependent
    • Does not improve asthma control better than regular follow-up
    •  PEF diaries can be unreliable
  • PEF can be useful in children with poor perception of airways obstruction or dysfunctional breathing (van den Wijngaart et al. 2015).
Forced Oscillation Technique (FOT) or Impulse Oscillation Technique (IOT)

Use pulse waves to measure resistance and reactance during tidal breathing. Studies specifically assessing use in children with severe asthma are lacking. Generally only available in tertiary care settings. For more information see Diagnosis –Lung Function Assessments

  • Can be useful in confirming bronchodilator response (BDR) in children that cannot perform spirometry. Bronchodilator response is defined using the 5th/95th centiles of the response to bronchodilators in healthy populations. These have been reported to be between −33 and −42 % for Rrs, 61 and 70 % for Xrs and approximately 80 % for AX, irrespective of the dose of the salbutamol (Hall et al. 2015).
  • Interpretation of test results requires clinical correlation (Shi et al. 2013, Schulze et al. 2016).

Fraction Exhaled Oxide (FeNO)

FeNO measures nitric oxide in exhaled breath, a biomarker of allergic / Type-2 inflammation in the airways. Specific evidence in children with severe asthma is lacking.  For more information see Diagnosis – Phenotyping

The main value of FeNO in children is as an assessment of adherence. FeNO levels drop quickly following inhaled corticosteroids (ICS) use, so ongoing high values on FeNO may indicate poor adherence.

A normal value supports an alternative diagnosis or non-eosinophilic inflammation causing asthma. There is very little evidence to support the use of FeNO as a monitoring tool over standard care, in children with severe asthma (Gomersal et al. 2016).

Interpretation of FeNO Results (Dweik et al. 2011, Bjermer et al. 2014)

Age Normal Elevated High
<12 years <15/20 ppb 15/20-35ppb >35ppb
>12 years <20-25 ppb 20/25-50 ppb >50ppb

Other Investigations

Allergy Testing and Eosinophil Quantification
Bronchoscopy and Chest CT scans
Induced Sputum or Bronchial Lavage Cell Counts (Phenotyping)
Allergy Testing and Eosinophil Quantification
  • Testing includes quantification of serum total IgE or specific IgE to allergens, and aeroallergen skin prick testing. Blood eosinophils may also be measured as a readout of systemic eosinophilic inflammation. For more information see Allergy Assessments & Phenotyping
  • Useful for the identification of potential allergen triggers
  • Desensitisation may be of benefit if only 1 major allergen is identified (e.g. house dust mite – HDM), but there is very limited literature in children (Compalati et al. 2009)
  • In severe asthma, mould allergens are common (Guilbert et al. 2014)
  • Allergic Bronchopulmonary Aspergillosis should be considered in adolescents with severe asthma (very rare)
  • Documentation of elevated levels is an eligibility criterion for targeted monoclonal antibody treatment (For more information see Medications in Paediatrics)
    • IgE levels for omalizumab
    • Peripheral blood eosinophil counts for mepolizumab
Bronchoscopy and Chest CT scans

True treatment refractory severe asthma in children is rare, so exclusion of alternative diagnoses should be considered, especially if treatment adherence has been assessed to be good [See Management in Paediatrics].

Bronchoscopy and chest CT scans may be useful and effective investigations to exclude alternative diagnoses, particularly if there is a history of chronic productive cough, poor response to bronchodilators or steroids or previous severe respiratory infections .

During bronchoscopy, bronchoalveolar lavage can be performed for microbiology, cell counts, and to investigate for lipid-laden macrophages to exclude infection and aspiration, respectively. Visualisation of the airways during dynamic breathing may diagnose bronchomalacia, as a cause of recurrent cough or wheeze.

CT is useful for evaluating:

  • Airway abnormalities and foreign bodies
  • Quantify the extent of small airways disease signified by gas trapping
  • Bronchial wall thickening
  • Bronchiectasis
  • Suspected interstitial lung disease

Low or normal dose CT chest is usually sufficient, but HRCT may be required to exclude interstitial lung disease, if clinically suggested (e.g. persistent hypoxia or diffuse changes on chest X-ray).

Induced Sputum or Bronchial Lavage Cell Counts (Phenotyping)

An inflammatory profile on lavage may be useful to help differentiate inflammation caused by eosinophils or neutrophils. For more information see Diagnosis – Phenotyping

  • This is a low value test in children, as sputum cellular phenotypes are not stable in paediatric patients longitudinally (Fleming et al. 2012). This may be related to high rates of viral infection in children, particularly for rhinovirus (approximately 12 infections per year) which causes neutrophilic lower airways inflammation in children with asthma

Tests for Alternative Diagnoses and Relevant Co-Morbidities

Psychological assessment
Impedance testing
Echocardiogram
Cardiopulmonary Exercise Testing
Nasal Nitric Oxide and Cilial Samples
Sweat test
Psychological assessment
  • See sub-section on Psychosocial Issues in Paediatrics
Impedance testing
  • Gastroesophageal reflux is a common co-morbidity in patients with severe asthma, although whether treatment is associated with an improvement in asthma control is contentious (Thakkar et al. 2010)
  • Impedance testing, with a 24-hour impedance probe is the most rigorous test for gastroesophageal reflux
  •  A treatment trial with proton pump inhibitors (PPIs) may be considered. For more information see Comorbidities – GORD
Echocardiogram
  • Echocardiogram is not recommended routinely but may be performed to exclude cardiogenic forms of wheeze (e.g. pulmonary hypertension or vascular compression of the airways)
  • Right ventricular dysfunction is associated with severe refractory asthma, therefore ECHO may be considered in those children with severe, persistent symptoms, particularly if there is evidence of hypoxia
Cardiopulmonary Exercise Testing
  • Should be considered particularly when spirometry is relatively normal and exercise symptoms are substantial
  • Cardiopulmonary exercise testing has a role in clarifying other differential diagnoses and contributing comorbidities.
Nasal Nitric Oxide and Cilial Samples
  • May be useful to exclude the diagnosis of primary ciliary dyskinesia, if symptoms of chronic or recurrent wet cough are present.
Sweat test
  • May be useful to exclude the alternative diagnosis of cystic fibrosis, if symptoms of chronic or recurrent wet cough are present.
Previous
Next

Last Updated on February 13, 2019

Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories

More results...

  • Overview
  • Management in Paediatrics
  • Assessment in Paediatrics
  • Alternative Diagnosis & Co-Morbidities in Paediatrics
  • Psychosocial Issues in Paediatrics
  • Medications in Paediatrics
  • Asthma in the Adolescent Population
Consider this information in conjunction with the relevant sections:
Diagnosis & Assessment
Management
Medications
Co-Morbidities

We want to know who accesses the Severe Asthma Toolkit and how it is used. Please complete our survey.

Responses will inform the continued development of the Severe Asthma Toolkit and future translation and implementation activities. Any feedback you provide will be greatly appreciated.

Complete Survey

  • Website Terms of Use
  • Website Survey
© Copyright 2018    CRICOS Provider Number 00109J    The University of Newcastle, Australia